| Biological Sciences | Lifetime | 934 | AU 23 | 99.89 |
| Biological Sciences | 2021-2025 | 122 | AU 5 | 99.89 |
| Medical and Health Sciences | 2021-2025 | 724 | AU 32 | 99.84 |
| Molecular Medicine | Lifetime | 14 | AU 1 | 99.73 |
| Clinical Pharmacology | Lifetime | 145 | AU 14 | 99.40 |
| Microbiology | Lifetime | 463 | AU 18 | 90.16 |
| Molecular Biology | 2021-2025 | 119 | AU 4 | 99.55 |
| Ecology | 2021-2025 | 113 | AU 15 | 98.86 |
| Molecular Medicine | 2021-2025 | 24 | AU 1 | 98.19 |
| Clinical Pharmacology | 2021-2025 | 110 | AU 14 | 96.34 |
| Epidemiology | 2021-2025 | 414 | AU 20 | 96.43 |
| Pulmonary and Respiratory Medicine | 2021-2025 | 562 | AU 25 | 93.65 |
| Microbiology | 2021-2025 | 66 | AU 6 | 90.66 |
| Immunology | 2021-2025 | 463 | AU 9 | 87.14 |
| Oncology | 2021-2025 | 694 | AU 24 | 89.24 |
| Biomaterials | 2021-2025 | 431 | AU 10 | 84.61 |
| Antibiotic Resistance in Bacteria | Lifetime | 19 | AU 1 | 99.90 |
| Antibiotics Pharmacokinetics and Efficacy | Lifetime | 15 | AU 2 | 99.88 |
| Pneumocystis jirovecii pneumonia detection and treatment | Lifetime | 56 | AU 2 | 99.49 |
| Pneumonia and Respiratory Infections | Lifetime | 163 | AU 5 | 99.31 |
| Pharmaceutical and Antibiotic Environmental Impacts | Lifetime | 202 | AU 12 | 99.00 |
| Antimicrobial Peptides and Activities | Lifetime | 328 | AU 17 | 97.25 |
| Drug Transport and Resistance Mechanisms | Lifetime | 692 | AU 26 | 97.32 |
| Autophagy in Disease and Therapy | Lifetime | 543 | AU 12 | 96.65 |
| Vibrio bacteria research studies | Lifetime | 551 | AU 18 | 96.30 |
| Inhalation and Respiratory Drug Delivery | Lifetime | 710 | AU 38 | 95.69 |
| Enterobacteriaceae and Cronobacter Research | Lifetime | 844 | AU 16 | 84.12 |
| Infections and bacterial resistance | Lifetime | 972 | AU 26 | 74.20 |
| Antibiotic Resistance in Bacteria | 2021-2025 | 27 | AU 1 | 99.46 |
| Antibiotics Pharmacokinetics and Efficacy | 2021-2025 | 28 | AU 2 | 98.90 |
| Bacteriophages and microbial interactions | 2021-2025 | 86 | AU 8 | 96.99 |
| Autophagy in Disease and Therapy | 2021-2025 | 286 | AU 6 | 91.55 |
| Antimicrobial Peptides and Activities | 2021-2025 | 215 | AU 11 | 91.14 |
| Pneumonia and Respiratory Infections | 2021-2025 | 476 | AU 22 | 91.82 |
| Antibiotic Use and Resistance | 2021-2025 | 576 | AU 18 | 89.88 |
| Invertebrate Immune Response Mechanisms | 2021-2025 | 294 | AU 1 | 84.57 |
| Physiological and biochemical adaptations | 2021-2025 | 530 | AU 32 | 82.40 |
| Pneumocystis jirovecii pneumonia detection and treatment | 2021-2025 | 862 | AU 23 | 77.98 |
| Vibrio bacteria research studies | 2021-2025 | 762 | AU 27 | 78.12 |
| Crustacean biology and ecology | 2021-2025 | 292 | AU 14 | 77.84 |
| Microbial infections and disease research | 2021-2025 | 816 | AU 59 | 75.21 |
| Silk-based biomaterials and applications | 2021-2025 | 761 | AU 15 | 72.34 |
| Advanced Glycation End Products research | 2021-2025 | 978 | AU 21 | 57.05 |
| Protein Interaction Studies and Fluorescence Analysis | 2021-2025 | 919 | AU 10 | 48.69 |
| Collagen: Extraction and Characterization | 2021-2025 | 918 | AU 8 | 45.38 |
